| ²é¿´: 319 | »Ø¸´: 0 | |||
TAINSTÌú³æ (ÕýʽдÊÖ)
|
[½»Á÷]
¸³ÐμÁµÄÈÈ·ÖÎö·½·¨
|
| Excipients are the components of a pharmaceutical formulation other than the active ingredient. Their purity, stability and other physical characteristics must be qualified along with those of the active component. Drug analysis methodology is often reported for excipients since these materials are universally available, and publication does not present an appearance of revealing trade secrets. Thermal analysis methods of drug analysis are reviewed and it is shown how DSC TzeroTM Technology improves the results. Detecting and characterizing polymorphs and pseudo-polymorphs and the characterization of amorphous formulations are described. |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ¸³ÐμÁµÄÈÈ·ÖÎö·½·¨.pdf
2017-01-11 10:46:22, 565.6 K
» ²ÂÄãϲ»¶
286Çóµ÷¼Á
ÒѾÓÐ25È˻ظ´
22ר˶Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
²ÄÁϹ¤³Ì281»¹Óе÷¼Á»ú»áÂð
ÒѾÓÐ19È˻ظ´
ҩѧ305Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
290Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
085410 273Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
0831Ò»ÂÖµ÷¼Áʧ°ÜÇóÖú
ÒѾÓÐ3È˻ظ´
271Çóµ÷¼Á
ÒѾÓÐ22È˻ظ´
Çóµ÷¼Á£¬985²ÄÁÏÓ뻯¹¤348·Ö
ÒѾÓÐ9È˻ظ´
344 ²ÄÁÏרҵ Çóµ÷¼Á211 ÎÞµØÓòÒªÇó
ÒѾÓÐ5È˻ظ´













»Ø¸´´ËÂ¥